Bio Rad Laboratories Inc (BIO) Files Form 4 Insider Selling : John Hertia Sells 228 Shares

Bio Rad Laboratories Inc (BIO): John Hertia , Executive Vice President of Bio Rad Laboratories Inc sold 228 shares on Sep 13, 2016. The Insider selling transaction was reported by the company on Sep 14, 2016 to the Securities and Exchange Commission. The shares were sold at $158.08 per share for a total value of $36,042.90 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 14, 2016, Shannon Hall (Executive Vice President) sold 92 shares at $158.08 per share price.On Sep 14, 2016, Michael Crowley (EVP, GBL Commercial Operations) sold 127 shares at $158.09 per share price.Also, On Sep 13, 2016, John Hertia (Executive Vice President) sold 3,417 shares at $156.80 per share price.On Sep 13, 2016, James R Stark (VP, Corporate Controller) sold 269 shares at $155.02 per share price.

Bio-Rad Laboratories: On Monday, Sep 12, 2016 heightened volatility was witnessed in Bio-Rad Laboratories which led to swings in the share price. The shares opened for trading at $155.21 and hit $159.84 on the upside , eventually ending the session at $159.32, with a gain of 1.02% or 1.61 points. The heightened volatility saw the trading volume jump to 138,665 shares. The 52-week high of the share price is $161.7 and the company has a market cap of $4,688 M . The 52-week low of the share price is at $122.03.

Bio-Rad Laboratories Money Flow Index Chart

Bio-Rad Laboratories Inc. (Bio-Rad) manufactures and supplies products and systems used for the life science research healthcare analytical chemistry and other markets. The Company offers products to separate complex chemical and biological materials and to identify analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops manufactures and markets a range of over 5000 reagents apparatus and laboratory instruments. The Company’s Clinical Diagnostics segment designs manufactures sells and supports test systems informatics systems test kits and quality controls that serve clinical laboratories in the global diagnostics market. Bio-Rad’s product brands include Droplet Digital and BioPlex. As of December 31 2014 the Company had direct distribution channels in over 35 countries outside the United States through subsidiaries.

Leave a Reply

Bio-Rad Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Bio-Rad Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.